Snapshot Camera for AMD

ID#: NCT03963817

Age: 60 - 90 years

Gender: All

Healthy Subjects: Accepts Healthy Volunteers

Recruitment Status: Recruiting

Start Date: September 06, 2023

End Date: February 01, 2024

Contact Information:
Katy Tai
212-979-4251
Harriet Lloyd
212-979-4672
Summary: This study proposes to use a new instrument (AO-OCT/AF: adaptive optics - optical coherence tomography/autofluorescence) combined with a data processing method to image the retinal pigment epithelium (RPE) of the eye in normal subjects and in subjects with age-related macular degeneration. (AMD). While currently there is no cure, with early diagnosis, vision loss can be slowed. The technology being developed for this project will be the first imaging modality that can provide both structural and molecular information about the retina in vivo and in 3D.
Eligibility:

Inclusion Criteria:

- Patients must be aged 60 and over and pseudophakic, with clear posterior capsule and dilation to 6mm.

- Patients must be diagnosed early/intermediate AMD in at least one eye (the study eye) with soft drusen or reticular pseudodrusen in the macula.

Exclusion Criteria:

- Retinopathy other than AMD.

- Inability to give informed consent

- Bilateral advanced AMD

- Allergy to dilation eye drops
Find a Clinical Trial Find Cancer Clinical Trials